| Business Summary | | Instrumentarium
Corp.
is
conducts
business
in
the
field
of
medical
technology
development,
manufacturing
and
marketing.
The
Company
is
also
involved
in
optical
retailing
in
Finland
and
nearby
markets.
Instrumentarium's
core
business
is
anesthesia
and
critical
care
represented
by
Datex-Ohmeda
and
Deio.
Instrumentarium
seeks
long-term,
profitable
growth
within
its
business
segments.
Four
of
Instrumentarium's
divisions,
Datex-Ohmeda,
Deio,
Instrumentarium
Imaging
and
Ohmeda
Medical
have
global
operations. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | INMRY
is
an
international
healthcare
company
concentrating
on
selected
fields
of
medical
technology
manufacturing,
marketing
and
distribution.
INMRY
is
also
involved
in
optical
retailing
in
Finland
and
its
neighboring
countries.
For
the
three
months
ended
3/31/01,
net
sales
rose
17%
to
EUR225.7
million.
Net
income
totaled
EUR10.9
million,
up
from
EUR800K.
Results
reflect
increased
sales
in
all
business
segments. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
240,600;
after
tax
earnings
were
11,200. (Preliminary; reported in thousands of Euro.) | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Gerhard Wendt, Ph.D. | Chairman | Olli Riikkala | Pres,
CEO | Matti Salmivuori | CFO | Richard Atkin | Pres
and CEO- Datex-Ohmeda North America | Chris Clough | Managing
Director, Distributor Sales, Datex-Ohmeda Division |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|